RECURRENCE OF PRIMARY (AL) AMYLOIDOSIS IN A TRANSPLANTED HEART WITH 4-YEAR SURVIVAL

被引：31
|
作者：
DUBREY, S [1 ]
SIMMS, RW [1 ]
SKINNER, M [1 ]
FALK, RH [1 ]
机构：
[1] BOSTON UNIV,SCH MED,DEPT MED,ARTHRITIS RES CTR,BOSTON,MA 02118
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 1995年 / 76卷 / 10期
关键词：
D O I：
10.1016/S0002-9149(99)80214-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We describe the course of a patient with severe cardiac amyloidosis who underwent cardiac transplantation and survived 47 months after surgery. The patient achieved a good quality of life for 3 years despite recurrence of amyloid in the transplanted heart.
引用
收藏
页码：739 / &
相关论文
共 50 条
  • [41] Complication and Survival of Mark II Restorations: 4-Year Clinical Follow-up
    Klink, Andrea
    Huettig, Fabian
    INTERNATIONAL JOURNAL OF PROSTHODONTICS, 2013, 26 (03) : 272 - 276
  • [42] Successful reuse of a transplanted kidney 9 years after initial transplantation: 4-year follow-up
    Wen-Hsin Tseng
    Yu-Feng Tian
    Alex Chien-Hwa Liao
    Ming-Jenn Chen
    Hsuan-Ying Ho
    Jinn-Rung Kuo
    Steven K. Huang
    BMC Nephrology, 19
  • [43] Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study
    Andrew Staron
    Luke Zheng
    Gheorghe Doros
    Lawreen H. Connors
    Lisa M. Mendelson
    Tracy Joshi
    Vaishali Sanchorawala
    Blood Cancer Journal, 11
  • [44] Successful reuse of a transplanted kidney 9 years after initial transplantation: 4-year follow-up
    Tseng, Wen-Hsin
    Tian, Yu-Feng
    Liao, Alex Chien-Hwa
    Chen, Ming-Jenn
    Ho, Hsuan-Ying
    Kuo, Jinn-Rung
    Huang, Steven K.
    BMC NEPHROLOGY, 2018, 19
  • [45] Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis
    Sidana, Surbhi
    Sidiqi, M. Hasib
    Dispenzieri, Angela
    Buadi, Francis K.
    Lacy, Martha Q.
    Muchtar, Eli
    Dingli, David
    Haynnan, Suzanne R.
    Gonsalves, Wilson, I
    Kapoor, Prashant
    Leung, Nelson
    Warsame, Rahma
    Kourelis, Taxiarchis, V
    Wolf, Robert C.
    Hogan, William J.
    Kumar, Shaji K.
    Gertz, Morie A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (09) : 1020 - 1026
  • [46] Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study
    Staron, Andrew
    Zheng, Luke
    Doros, Gheorghe
    Connors, Lawreen H.
    Mendelson, Lisa M.
    Joshi, Tracy
    Sanchorawala, Vaishali
    BLOOD CANCER JOURNAL, 2021, 11 (08)
  • [47] The evolution of liver stiffness predicts 4-year survival of patients with chronic hepatitis C
    Vergniol, Julien
    Boursier, Jerome
    Coutzac, Clelia
    Bertrais, Sandrine
    Foucher, Juliette
    Angel, Camille
    Chermak, Faiza
    Fouchard-Hubert, Isabelle
    Merrouche, Wassil
    Oberti, Frederic
    de Ledinghen, Victor
    Cales, Paul
    HEPATOLOGY, 2012, 56 : 682A - 682A
  • [48] REDUCED SURVIVAL IN LAMBDA PREDOMINANT CARDIAC AL AMYLOIDOSIS PATIENTS AWAITING ORTHOTOPIC HEART TRANSPLANT
    Tabtabai, Sara
    Niehaus, Emily
    Sarswat, Nitasha
    Stone, James R.
    Maurer, Mathew
    Witteles, Ronald
    Estep, Jerry
    Baran, David
    Zucker, Mark
    Feltrin, Guiseppe
    Seldin, David
    Semigran, Marc
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A930 - A930
  • [49] Extent of hematologic response is important in determining outcome in transplanted patients with primary amyloidosis AL. Importance of achieving CR
    Hayman, S. R.
    Lacy, M. Q.
    Dispenzieri, A.
    Kumar, S. K.
    Gastineau, D. A.
    Gertz, M. A.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2006, 13 : 31 - 31
  • [50] Long-term survival (10+ years) in 30 patients with primary amyloidosis (AL).
    Kyle, RA
    Gertz, MA
    Greipp, PR
    Witzig, TE
    Lust, JA
    Lacy, MQ
    Therneau, TM
    BLOOD, 1997, 90 (10) : 375 - 375
12345